ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Effect of T on Cardiovascular Disease and Risk
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 205001" data-attributes="member: 13851"><p><em><strong>*<u>Adequately powered randomized clinical trials designed to assess cardiovascular events are required to definitively determine the effect of testosterone therapy on cardiovascular risk</u>. The <u>TRAVERSE trial</u> is an ongoing clinical trial designed to measure the time to MACE in hypogonadal males, aged 45 to 80 years, with increased risk or evidence of CVD. 36 The study commenced in May 2018 and is expected to be complete in June 2022, with 6000 planned participants randomized to topical testosterone or placebo.36 <u>This clinical trial will play an important role in determining the safety of TRT in hypogonadal males</u>.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 205001, member: 13851"] [I][B]*[U]Adequately powered randomized clinical trials designed to assess cardiovascular events are required to definitively determine the effect of testosterone therapy on cardiovascular risk[/U]. The [U]TRAVERSE trial[/U] is an ongoing clinical trial designed to measure the time to MACE in hypogonadal males, aged 45 to 80 years, with increased risk or evidence of CVD. 36 The study commenced in May 2018 and is expected to be complete in June 2022, with 6000 planned participants randomized to topical testosterone or placebo.36 [U]This clinical trial will play an important role in determining the safety of TRT in hypogonadal males[/U].[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Effect of T on Cardiovascular Disease and Risk
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top